Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumorsV M Macaulay, M R Middleton, A S Protheroe, et al.Investigational New Drugs|January 1, 1997
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID miceL Polin, F Valeriote, K White, et al.ESMO Open|October 24, 2025
Phase Ib study of xentuzumab and abemaciclib in patients with advanced solid tumors and in combination with endocrine therapy in patients with advanced breast cancerD Yee, H Iwata, P LoRusso, et al.ESMO Open|December 25, 2021
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspectiveC Sessa, J Cortes, P Conte, et al.Clinical Pharmacology and Therapeutics|October 29, 2010
A phase I study of the pharmacokinetic and safety profiles of oral pazopanib with a high-fat or low-fat meal in patients with advanced solid tumorsE I Heath, E G Chiorean, C J Sweeney, et al.Investigational New Drugs|December 16, 1998
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical TrialsJ-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.British Journal of Cancer|June 2, 2011
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyC R Garrett, L L Siu, A El-Khoueiry, et al.Investigational New Drugs|November 11, 1999
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human originT H Corbett, C Panchapor, L Polin, et al.Journal of Experimental Therapeutics & Oncology|March 1, 1996
Preclinical anticancer activity of cryptophycin-8T H Corbett, F A Valeriote, L Demchik, et al.Pageof 5